Science-Driven Innovation
ActiveImmunity has developed and patented its own process for extracting and stabilizing IgY without compromising biological activity. The method involves controlled hen immunization followed by low-temperature purification (below 30°C), preserving the full function of the antibodies and allowing for clean, additive-free formulations.

What Sets ActiveImmunity Apart?

• Ethical sourcing: IgY is harvested from eggs — a renewable, cruelty-free source
• Patented technology: A unique, validated process with proven pathogen-neutralizing power
• Versatility: Formulations available as tablets, sprays, gels, creams, and more — for human, veterinary, or industrial use
• Resistance-free: IgY does not induce microbial resistance or affect the beneficial flora
• Customization: The platform supports targeted antibody development for specific pathogens

Scientifically Validated Results
In preclinical testing, ActiveImmunity’s formulations demonstrated bacterial neutralization rates of 85% to 99% against pathogens like Staphylococcus aureus, Escherichia coli, Salmonella, and Clostridium difficile. The products have passed rigorous safety and efficacy assessments at the preclinical level.

A Platform with Global Reach
Though based in Romania, ActiveImmunity aligns with global biotech trends. The company collaborates with academic institutions and international partners in health, nutrition, and sustainability — building a scalable and innovative biotech platform with long-term impact.

ActiveImmunity is more than a supplement producer — it is a biotechnology platform redefining immune health through science, ethics, and sustainability. By combining rigorous research with natural innovation, it is setting a new standard for preventive medicine.

Praesent nec ex eget nulla porttitor cursus. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Nunc ac imperdiet lectus. Etiam vestibulum nunc orci, ut ultrices tortor placerat at.